{"id":"https://openalex.org/W2157378263","doi":"https://doi.org/10.4049/jimmunol.1402140","title":"In Vivo Maintenance of Human Regulatory T Cells during CD25 Blockade","display_name":"In Vivo Maintenance of Human Regulatory T Cells during CD25 Blockade","publication_year":2014,"publication_date":"2014-01-01","ids":{"openalex":"https://openalex.org/W2157378263","doi":"https://doi.org/10.4049/jimmunol.1402140","mag":"2157378263","pmid":"https://pubmed.ncbi.nlm.nih.gov/25416807"},"language":"en","primary_location":{"id":"doi:10.4049/jimmunol.1402140","doi":"https://doi.org/10.4049/jimmunol.1402140","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.1402140","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5023410113","display_name":"David J. Huss","orcid":"https://orcid.org/0009-0009-9887-3013","observed_orcids":["https://orcid.org/0009-0009-9887-3013","https://orcid.org/0000-0002-3239-8477"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David J Huss","raw_affiliation_strings":["Biogen Idec , Cambridge, MA 02142","*Biogen Idec, Cambridge, MA 02142; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec , Cambridge, MA 02142","institution_ids":["https://openalex.org/I1297540436"]},{"raw_affiliation_string":"*Biogen Idec, Cambridge, MA 02142; and","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109410605","display_name":"Devangi S. Mehta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Devangi S Mehta","raw_affiliation_strings":["Biogen Idec , Cambridge, MA 02142","*Biogen Idec, Cambridge, MA 02142; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec , Cambridge, MA 02142","institution_ids":["https://openalex.org/I1297540436"]},{"raw_affiliation_string":"*Biogen Idec, Cambridge, MA 02142; and","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003920550","display_name":"Akanksha Sharma","orcid":"https://orcid.org/0000-0001-6321-0564","observed_orcids":["https://orcid.org/0000-0001-6321-0564"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Akanksha Sharma","raw_affiliation_strings":["Biogen Idec , Cambridge, MA 02142","*Biogen Idec, Cambridge, MA 02142; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec , Cambridge, MA 02142","institution_ids":["https://openalex.org/I1297540436"]},{"raw_affiliation_string":"*Biogen Idec, Cambridge, MA 02142; and","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103278783","display_name":"Xiaojun You","orcid":"https://orcid.org/0000-0003-3108-7359","observed_orcids":["https://orcid.org/0000-0003-3108-7359"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Xiaojun You","raw_affiliation_strings":["Biogen Idec , Cambridge, MA 02142","*Biogen Idec, Cambridge, MA 02142; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec , Cambridge, MA 02142","institution_ids":["https://openalex.org/I1297540436"]},{"raw_affiliation_string":"*Biogen Idec, Cambridge, MA 02142; and","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060518146","display_name":"Katherine A. Riester","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Katherine A Riester","raw_affiliation_strings":["Biogen Idec , Cambridge, MA 02142","*Biogen Idec, Cambridge, MA 02142; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec , Cambridge, MA 02142","institution_ids":["https://openalex.org/I1297540436"]},{"raw_affiliation_string":"*Biogen Idec, Cambridge, MA 02142; and","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016720231","display_name":"James P. Sheridan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405280693","display_name":"AbbVie Biotherapeutics (United States)","ror":"https://ror.org/03a0g6939","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688","https://openalex.org/I4405280693"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James P Sheridan","raw_affiliation_strings":["\u2020AbbVie Biotherapeutics, Redwood City, CA 94063"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u2020AbbVie Biotherapeutics, Redwood City, CA 94063","institution_ids":["https://openalex.org/I4405280693"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052546923","display_name":"Lakshmi S. Amaravadi","orcid":"https://orcid.org/0009-0008-1720-3249","observed_orcids":["https://orcid.org/0009-0008-1720-3249"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lakshmi S Amaravadi","raw_affiliation_strings":["Biogen Idec , Cambridge, MA 02142","*Biogen Idec, Cambridge, MA 02142; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec , Cambridge, MA 02142","institution_ids":["https://openalex.org/I1297540436"]},{"raw_affiliation_string":"*Biogen Idec, Cambridge, MA 02142; and","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108457840","display_name":"Jacob S Elkins","orcid":"https://orcid.org/0009-0000-5898-8937","observed_orcids":["https://orcid.org/0009-0000-5898-8937"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob S Elkins","raw_affiliation_strings":["Biogen Idec , Cambridge, MA 02142","*Biogen Idec, Cambridge, MA 02142; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec , Cambridge, MA 02142","institution_ids":["https://openalex.org/I1297540436"]},{"raw_affiliation_string":"*Biogen Idec, Cambridge, MA 02142; and","institution_ids":["https://openalex.org/I1297540436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087072417","display_name":"Jason D. Fontenot","orcid":"https://orcid.org/0000-0002-5106-0519","observed_orcids":["https://orcid.org/0000-0002-5106-0519"]},"institutions":[{"id":"https://openalex.org/I1297540436","display_name":"Biogen (United States)","ror":"https://ror.org/02jqkb192","country_code":"US","type":"company","lineage":["https://openalex.org/I1297540436"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jason D Fontenot","raw_affiliation_strings":["Biogen Idec , Cambridge, MA 02142","*Biogen Idec, Cambridge, MA 02142; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biogen Idec , Cambridge, MA 02142","institution_ids":["https://openalex.org/I1297540436"]},{"raw_affiliation_string":"*Biogen Idec, Cambridge, MA 02142; and","institution_ids":["https://openalex.org/I1297540436"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5003920550","https://openalex.org/A5103278783"],"corresponding_institution_ids":["https://openalex.org/I1297540436"],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":3.3196,"has_fulltext":false,"cited_by_count":56,"citation_normalized_percentile":{"value":0.92894019,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"194","issue":"1","first_page":"84","last_page":"92"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9980000257492065},{"id":"https://openalex.org/keywords/daclizumab","display_name":"daclizumab","score":0.9359999895095825},{"id":"https://openalex.org/keywords/il-2-receptor-alpha","display_name":"IL-2 receptor alpha","score":0.8949999809265137},{"id":"https://openalex.org/keywords/foxp3","display_name":"Foxp3","score":0.6240000128746033},{"id":"https://openalex.org/keywords/treg-homeostasis","display_name":"Treg homeostasis","score":0.8769999742507935},{"id":"https://openalex.org/keywords/interleukin-2","display_name":"interleukin-2","score":0.7080000042915344},{"id":"https://openalex.org/keywords/stat5-signaling","display_name":"STAT5 signaling","score":0.7799999713897705},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.8790000081062317},{"id":"https://openalex.org/keywords/autoimmune-disease","display_name":"autoimmune disease","score":0.5139999985694885}],"concepts":[{"id":"https://openalex.org/C2779719350","wikidata":"https://www.wikidata.org/wiki/Q412920","display_name":"Daclizumab","level":4,"score":0.90898597240448},{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.8456487655639648},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.7746860980987549},{"id":"https://openalex.org/C2778468042","wikidata":"https://www.wikidata.org/wiki/Q273976","display_name":"Blockade","level":3,"score":0.5507567524909973},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.5482195615768433},{"id":"https://openalex.org/C2778296632","wikidata":"https://www.wikidata.org/wiki/Q1550619","display_name":"Regulatory T cell","level":5,"score":0.5096793174743652},{"id":"https://openalex.org/C2780130043","wikidata":"https://www.wikidata.org/wiki/Q192360","display_name":"Autoimmunity","level":3,"score":0.4768843948841095},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.46135473251342773},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.43779298663139343},{"id":"https://openalex.org/C2777702733","wikidata":"https://www.wikidata.org/wiki/Q1356761","display_name":"Immune tolerance","level":3,"score":0.4251098930835724},{"id":"https://openalex.org/C123982805","wikidata":"https://www.wikidata.org/wiki/Q6046964","display_name":"Interleukin-7 receptor","level":5,"score":0.41159534454345703},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4050157070159912},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3775046169757843},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3615038990974426},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3461984395980835},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.34205925464630127},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.22361290454864502},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18340688943862915},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.13376545906066895}],"mesh":[{"descriptor_ui":"D000077561","descriptor_name":"Daclizumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007074","descriptor_name":"Immunoglobulin G","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007376","descriptor_name":"Interleukin-2","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011401","descriptor_name":"Promoter Regions, Genetic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017634","descriptor_name":"Self Tolerance","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017634","descriptor_name":"Self Tolerance","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020381","descriptor_name":"Interleukin-17","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D020381","descriptor_name":"Interleukin-17","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D050378","descriptor_name":"T-Lymphocytes, Regulatory","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D050799","descriptor_name":"STAT5 Transcription Factor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051858","descriptor_name":"Forkhead Transcription Factors","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D051858","descriptor_name":"Forkhead Transcription Factors","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D051858","descriptor_name":"Forkhead Transcription Factors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053631","descriptor_name":"Interleukin Receptor Common gamma Subunit","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D053645","descriptor_name":"Interleukin-2 Receptor alpha Subunit","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D053645","descriptor_name":"Interleukin-2 Receptor alpha Subunit","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D053646","descriptor_name":"Interleukin-2 Receptor beta Subunit","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.4049/jimmunol.1402140","doi":"https://doi.org/10.4049/jimmunol.1402140","is_oa":false,"landing_page_url":"https://doi.org/10.4049/jimmunol.1402140","pdf_url":null,"source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},{"id":"pmid:25416807","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25416807","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of immunology (Baltimore, Md. : 1950)","raw_type":"Clinical Trial, Phase II"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":50,"referenced_works":["https://openalex.org/W1499151513","https://openalex.org/W1548506283","https://openalex.org/W1568663209","https://openalex.org/W1697418081","https://openalex.org/W1966972158","https://openalex.org/W1970062660","https://openalex.org/W1971516038","https://openalex.org/W1973647796","https://openalex.org/W1974313653","https://openalex.org/W1975389005","https://openalex.org/W1977836556","https://openalex.org/W1982180094","https://openalex.org/W1986297885","https://openalex.org/W1989354231","https://openalex.org/W1989516288","https://openalex.org/W1992957230","https://openalex.org/W2002726823","https://openalex.org/W2007631222","https://openalex.org/W2018011490","https://openalex.org/W2023560778","https://openalex.org/W2034430001","https://openalex.org/W2049452608","https://openalex.org/W2050792244","https://openalex.org/W2051213845","https://openalex.org/W2059452586","https://openalex.org/W2064376469","https://openalex.org/W2073672027","https://openalex.org/W2074863919","https://openalex.org/W2081360252","https://openalex.org/W2081395451","https://openalex.org/W2090069133","https://openalex.org/W2095671247","https://openalex.org/W2097811455","https://openalex.org/W2101409687","https://openalex.org/W2101684276","https://openalex.org/W2106804464","https://openalex.org/W2112079575","https://openalex.org/W2113485611","https://openalex.org/W2116460145","https://openalex.org/W2124626123","https://openalex.org/W2141649011","https://openalex.org/W2149804459","https://openalex.org/W2150747144","https://openalex.org/W2150901150","https://openalex.org/W2152642587","https://openalex.org/W2153142861","https://openalex.org/W2154468886","https://openalex.org/W2161469000","https://openalex.org/W2167414238","https://openalex.org/W2169820627"],"related_works":["https://openalex.org/W1658248263","https://openalex.org/W3093001787","https://openalex.org/W1973647796","https://openalex.org/W2154468886","https://openalex.org/W2148083116","https://openalex.org/W593906068","https://openalex.org/W1986297885","https://openalex.org/W2486595797","https://openalex.org/W2058682322","https://openalex.org/W7027651622"],"abstract_inverted_index":{"Regulatory":[0],"T":[1],"cells":[2,107],"(Tregs)":[3],"mediate":[4],"immune":[5],"tolerance":[6],"to":[7,40],"self":[8],"and":[9,18,66,122,130,141,148,171],"depend":[10],"on":[11,81],"IL-2":[12,38,58,68,137],"for":[13],"homeostasis.":[14],"Treg":[15,82,152,169],"deficiency,":[16],"dysfunction,":[17],"instability":[19],"are":[20],"implicated":[21],"in":[22,33,84,99,114,177],"the":[23,37,57,75,115,133,178],"pathogenesis":[24],"of":[25,36,77,126,135,180],"numerous":[26],"autoimmune":[27],"diseases.":[28],"There":[29],"is":[30,51],"considerable":[31],"interest":[32],"therapeutic":[34],"modulation":[35],"pathway":[39],"treat":[41],"autoimmunity,":[42],"facilitate":[43],"transplantation":[44],"tolerance,":[45],"or":[46,64,161],"potentiate":[47],"tumor":[48],"immunotherapy.":[49],"Daclizumab":[50],"a":[52,60,63,102,109],"humanized":[53],"mAb":[54],"that":[55,92,168],"binds":[56],"receptor":[59],"subunit":[61],"(IL-2R":[62],"CD25)":[65],"prevents":[67],"binding.":[69],"In":[70,132],"this":[71],"study,":[72],"we":[73],"investigated":[74],"effect":[76],"daclizumab-mediated":[78],"CD25":[79,181],"blockade":[80],"homeostasis":[83],"patients":[85],"with":[86,157],"relapsing-remitting":[87],"multiple":[88],"sclerosis.":[89],"We":[90],"report":[91],"daclizumab":[93],"therapy":[94],"caused":[95],"an":[96],"~50%":[97],"decrease":[98],"Tregs":[100],"over":[101],"52-wk":[103],"period.":[104],"Remaining":[105],"FOXP3+":[106],"retained":[108],"demethylated":[110,112],"Treg-specific":[111],"region":[113],"FOXP3":[116,150],"promoter,":[117],"maintained":[118,176],"active":[119],"cell":[120],"cycling,":[121],"had":[123],"minimal":[124],"production":[125],"IL-2,":[127],"IFN-":[128],"g,":[129],"IL-17.":[131],"presence":[134],"daclizumab,":[136],"serum":[138],"concentrations":[139],"increased":[140],"IL-2R":[142],"bg":[143],"signaling":[144],"induced":[145],"STAT5":[146],"phosphorylation":[147],"sustained":[149],"expression.":[151],"declines":[153],"were":[154],"not":[155],"associated":[156],"daclizumab-related":[158],"clinical":[159],"benefit":[160],"cutaneous":[162],"adverse":[163],"events.":[164],"These":[165],"results":[166],"demonstrate":[167],"phenotype":[170],"lineage":[172],"stability":[173],"can":[174],"be":[175],"face":[179],"blockade.":[182]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":6},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":14},{"year":2015,"cited_by_count":5}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}